NASDAQ:NVAX | Free Cash Flow | NOVAVAX INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$32.42M
2025-12-31-$39.48M
2025-03-31-$185.5M
2024-12-31-$173.16M
2024-03-31-$83.56M
2023-12-31-$176.78M
2023-03-31-$325.59M
2022-12-31-$117.82M
2022-03-31-$88.51M
2021-12-31-$342.41M
2021-03-31$663.09M
2020-12-31-$128.57M
2020-03-31-$23.11M
2019-12-31-$23.74M
2019-03-31-$50.61M
2018-12-31-$45.27M
2018-03-31-$66.08M
2017-12-31-$43.4M
2017-03-31-$44.5M
2016-12-31-$64.55M
2016-03-31-$69.83M
2015-12-31-$54.75M
2015-03-31-$30.49M
2014-12-31-$19.77M
2014-03-31-$20.43M
2013-12-31-$12.26M
2013-03-31-$10.58M
2012-12-31-$3.25M
2012-03-31-$4.22M
2011-12-31-$2.87M
2011-03-31-$9.04M
2010-12-31-$5.81M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$244.64M
2024-12-31-$87.26M
2023-12-31-$713.97M
2022-12-31-$415.94M
2021-12-31$322.95M
2020-12-31-$42.54M
2019-12-31-$136.62M
2018-12-31-$184.83M
2017-12-31-$144.48M
2016-12-31-$258.77M
2015-12-31-$126.09M
2014-12-31-$67.01M
2013-12-31-$45.36M
2012-12-31-$18.23M
2011-12-31-$23.63M
2010-12-31-$32.85M
2009-12-31-$32.83M